Cizzle secures Canadian patent for lung cancer test format
(Alliance News) - Cizzle Biotechnology Holdings PLC on Wednesday said the Canadian intellectual property office has granted protection to medical testing methods that use the CIZ1B lung cancer biomarker. Read More